TY - JOUR AU - Ashish Kale*, AU - Shital Mane, AU - Raviteja Mane, PY - 2019/01/19 Y2 - 2024/03/29 TI - STUDY THE EFFECT OF NAVAK GUGGULU IN THE MANAGEMENT OF AMAVATA JF - AYUSHDHARA JA - Ayushdhara VL - 5 IS - 5 SE - DO - UR - https://ayushdhara.in/index.php/ayushdhara/article/view/421 SP - 1908-1918 AB - <p><em>Amavata</em> is one of the challenging diseases for the physicians due to its Chronicity, incurability, complications and morbidity. Though, <em>Ama</em> and <em>Vata</em> are the predominant pathogenic factors but the disease represents <em>Tridoshic</em> vitiation. <em>Vata</em> is the prime moreover and motivator in the human body, responsible for the initiation of every kind of activity. The affliction of <em>Sandhis</em> by <em>Vata Dosha</em> in association with <em>Ama</em> reflects the equal rate of the both <em>Dosha</em> and <em>Dushyas</em> in the causation of this disease. The aim is to study the effect of <em>Navak guggulu</em> in the management of <em>Amavata</em>. 30 patients of <em>Amavata</em> having textual symptomtology from the text <em>Madhava Nidana</em> were randomly selected and enrolled in to the study.</p><p><em>Nakaradi guggulu prakarnam</em> mentioned <em>Navak Guggulu </em>is as like nectar in the management of <em>Amavata. Shunthi, Maricha, Pippali, Chitraka</em>, <em>Haritaki, Bibhitaka, Amalaki, Nagar Motha, Vidanga</em> and <em>Guggulu</em> are the ten ingredients of this formulation. In <em>Navaka Guggulu</em> maximum ingredients have <em>Rasa- Katu, Virya -Ushna, Vipaka- Katu, Guna-laghu</em>, <em>Ruksha</em>. So <em>Vata -Kaphashamaka</em> may be effective to control <em>Amavata</em>.</p><p>The trial drug in this study was very effective in <em>Agnivardhana</em> and <em>Amapachana</em>. It was a very good combination of <em>Shoolahara, Shothaghna</em> and <em>Amapachaka Dravyas. Navak Guggulu</em> is very effective in reducing pain and stiffness.</p><p>As far as relief of symptoms were concerned, no patient got good result (no complaints), 10 patients got moderate result (i.e. 2-step down). 14 patients got mild result (i.e. 1-step down), and 6 patient got no result i.e. no change in complaints.</p> ER -